Focused on targeted therapies for Parkinson’s disease.
Kifa Therapeutics, Inc.
01 Introduction
Kifa Therapeutics develops precision small-molecule therapies targeting genetically defined Parkinson’s disease.
Kifa Therapeutics develops precision small-molecule therapies targeting genetically defined Parkinson’s disease.